Research Article
Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors
Table 3
Cox regression analyses: time until first dispensing date of levodopa for patients under 72 years, the final model (baseline in parentheses).
| Variable | HR | CI | value |
| Age | 1.054 | (1.043, 1.065) | <0.001 | Gender (male) | 0.609 | (0.541, 0.685) | <0.001 | Drugs for diabetes (none) | 0.824 | (0.659, 1.03) | 0.089 | Drugs for hypertension (none) | 0.816 | (0.664, 1.003) | 0.053 | Drugs for atrial fibrillation (none) | 0.888 | (0.777, 1.014) | 0.080 | 1st prescription from specialist (not specialist) | 2.003 | (1.446, 2.775) | <0.001 | Dopamine agonist user (MAO-B inhibitor user) | 0.101 | (0.088, 0.118) | <0.001 |
|
|